期刊
CIRCULATION RESEARCH
卷 100, 期 10, 页码 1415-1427出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/01.RES.0000266449.37396.1f
关键词
atherosclerosis; diabetes mellitus; diabetic cardiomyopathy; transgenic mice
资金
- NHLBI NIH HHS [HL70523, U01 HL087946, HL70526, HL87944, HL87945, HL70524, HL70525, HL87947] Funding Source: Medline
- NIDDK NIH HHS [DK76169, DK60966] Funding Source: Medline
For more than 50 years, investigators have unsuccessfully tried to recreate in experimental animals the cardiovascular complications of diabetes seen in humans. In particular, accelerated atherosclerosis and dilated cardiomyopathy, the major causes of mortality in patients with diabetes, have been conspicuously absent in many mouse models of the disease. Under the auspices of the NIH, the Animal Models of Diabetic Complications Consortium has worked to address this issue. This effort has focused on the development of mouse models because of the high level of genomic information available and the many well-developed genetic manipulations that may be performed in mice. Importantly, the consortium has also worked to standardize many methods to assess metabolic and cardiovascular end points for measurement of the diabetic state and its macrovascular complications. Finally, for maximum benefits from these animal models in the study of atherosclerosis and of other diabetic complications, the consortium has created a system for sharing both the animal models and the accumulated phenotypic data with the greater scientific community.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据